ALS Association

=====================

The ALS Association is a nonprofit organization dedicated to fighting Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease. Founded in 1968 by Dr. James Nance, the organization provides support and resources to individuals affected by ALS.

History

The ALS Association was established after Dr. Nance, a neurologist at Johns Hopkins University, witnessed firsthand the devastating effects of ALS on his wife, who had been diagnosed with the disease. He realized that there was no cure for ALS, but he believed that awareness and research could help improve the lives of those affected.

Mission

The mission of the ALS Association is to “find a cure for Amyotrophic Lateral Sclerosis (ALS), support its victims and their families, and advocate for public policies that promote research into the disease.” The organization also aims to raise awareness about ALS through education, research, and advocacy.

Services and Programs

The ALS Association offers a wide range of services and programs designed to support individuals affected by ALS. Some of these include:

  • Clinical trials Program: The association’s Clinical trials program provides access to cutting-edge treatments and therapies for patients with ALS.
  • Support Groups: Support groups provide a safe space for individuals with ALS, their families, and caregivers to connect with others who understand the challenges they face.
  • Education and Research: The organization supports research into the causes of ALS, as well as education about the disease, its symptoms, and its effects on patients and their families.
  • Advocacy: The ALS Association advocates for policies that promote research, increase funding, and improve access to care for individuals with ALS.

Research

The ALS Association is committed to advancing our understanding of ALS through research. Some of the key areas of focus include:

  • Genetic Research: The organization seeks to identify the Genetic basis of ALS and develop new treatments based on this knowledge.
  • Neuroimaging research: Researchers at the association are exploring new imaging techniques that can help diagnose and monitor ALS more effectively.
  • Mechanistic Studies: Scientists are studying the Molecular mechanisms underlying ALS to better understand the disease’s progression.

Clinical trials

The ALS Association is involved in numerous Clinical trials aimed at developing new treatments for ALS. These trials are designed to evaluate the safety, efficacy, and optimal dosing of various therapies, including:

  • Riluzole: Riluzole, also known as rilutek, is a medication that has been shown to slow the progression of ALS.
  • Globezumab: Globezumab is an antibody therapy that targets a specific protein involved in ALS.

Advocacy

The ALS Association advocates for policies that promote research into ALS and increase funding for this critical area of study. Some key initiatives include:

  • Legislative Action: The organization works with lawmakers to push for legislation that supports ALS research, such as the ALS Research Act.
  • Public Awareness Campaigns: The ALS Association launches public awareness campaigns to educate the public about ALS and its effects on patients and their families.

Funding

The ALS Association relies heavily on donations to support its programs and services. Some of the key funding sources include:

  • Grants from National Institutes of Health (NIH): The organization receives funding from the NIH to support research initiatives.
  • Donations: Donations from individuals, foundations, and corporations help support the association’s daily operations.

Board of Directors

The ALS Association has a diverse board of directors that includes:

  • James Nance Jr.: Founder and former CEO of the organization
  • Dr. Roberta C. Smith: Neurologist and former chair of the National Institute of Neurological Disorders and Stroke (NINDS)
  • Dr. Stephen H. Hawley: Professor of neuroscience at Johns Hopkins University

Funding Request

The ALS Association is seeking $150 million to support its programs and services in 2023-2024. The organization has allocated funds for:

  • Clinical trials Program: $20 million to support new Clinical trials.
  • Support Groups: $10 million to maintain and expand the association’s support group network.
  • Education and Research: $30 million to advance our understanding of ALS.

Glossary

References

External Links

  • American Red Cross: ALS Association
  • Johns Hopkins University: The ALS Foundation